Company: BIVIW
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001520138-25-000144
Chunk: 66

Company: BIOVIE INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 8
Chunk 66
---
 Value Measurements at 

    March 31, 2025 

    Level 1  
    Level 2  
    Level 3  
    Total 

    Cash 
    $8,007,601  
    $-  
    $-  
    $8,007,601 
  
    U.S. Treasury Bills due in 3 months or less at purchase 
     15,144,413  
     -  
     -  
     15,144,413 

    Total 
    $23,152,014  
    $-  
    $-  
    $23,152,014 

    Fair Value Measurements at 

    June 30, 2024 

    Level 1  
    Level 2  
    Level 3  
    Total 

    Cash 
    $12,763,941  
    $-  
    $-  
    $12,763,941 
  
    U.S. Treasury Bills due in 3 months or less at purchase 
     11,079,857  
     -  
     -  
     11,079,857 

    Total 
    $23,843,798  
    $-  
    $-  
    $23,843,798 

    8.
    Equity Transactions

Issuance of common stock for cash

On March 6, 2024, the Company closed a best efforts
public offering (the “Offering”) of 15,000,000
shares (the “Shares”) of its Common Stock, pre-funded warrants (the “Pre-funded Warrants”) to purchase
6,000,000
shares of Common Stock, and warrants to purchase up to 10,500,000
shares of Common Stock (the “Common Warrants”) at a combined public offering price of $1.00
per Share, or Pre-funded Warrant, and the associated Common Warrant. The Common Warrants have an
exercise price of $1.50
per share and are immediately exercisable upon issuance for a period of five years following the
date of issuance. The gross proceeds to the Company from the Offering were approximately $21.0
million, before deducting placement agent fees and offering expenses of approximately $2.5 million. Additionally, upon closing the Company
issued the placement agent warrants (“Placement Agent